Stanford University Microbiome Bank
ConditionHealthy Adult Participants
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorSean Spencer
About this trial
This protocol establishes a centralized stool donor bank and research platform to support microbiota transplantation therapy (MTT) for microbiota-mediated diseases. The study will characterize donor microbiome, metabolite, immune, and dietary profiles.
Eligibility criteria
Qualifiers
Provision of signed and dated informed consent form
Stated willingness to comply with all study procedures and availability for the duration of the study
Any person aged 18-80 years of age, inclusive at the time of signing the consent
In good general health as evidenced by medical history
Disqualifiers
Inflammatory bowel disease
Enteric infections
Previous infection with Clostridium difficile
History of gastrointestinal surgery: Participants with gastrointestinal surgeries below the pylorus will be excluded from this protocol, including participants with a history of colectomy, segmental colonic resection, and small bowel resections.
Trial design
Treatments tested in this trial
- Microbiome bank
Treatment groups
50 Participants
are divided into 1 treatment groupSponsors and collaborators
Sean Spencer
Lead sponsor
Stanford University
Sponsor institution
Kepner Microbiome Fund
Collaborator
Mischa Deeter Research Fund
Collaborator
GI Diseases Fund
Collaborator
Source ClinicalTrials.gov